Work

Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis

Year: 2017
Type: review
Abstract: // Jie-Hui Zhong 1 , Dan-Hui Huang 1 and Zi-Yu Chen 1 1 Department of Clinical Medicine, The First Clinical Medical College, Southern Medical University, Guangzhou, 510515, China Correspondence to: Jie-Hui Zhong, email: [email protected] Keywords: systemic immune-inflammation index, solid tumors, meta-analysis Received: April 05, 2017 Accepted: June 10, 2017 Published: June 29, 2017 ABSTRACT Background: Inflammation may play an important role in cancer progression, and a higher systemic immune-inflammation index (SII) has been reported to be a poor prognostic marker in several malignancies. However, the results of published studies are inconsistent. Materials and Methods: A systematic review of databases was conducted to search for publications regarding the association between blood SII and clinical outcome in solid tumors with a date up to February 12, 2017. The primary outcome was overall survival (OS) and the secondary outcomes were progression-free survival (PFS) and cancer-specific survival (CSS). Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were used to assess the strength of the association between blood SII and clinical outcome in solid tumors. Results: A total of 15 articles were included in the analysis. Overall, systemic immune-inflammation index greater than the cutoff predicted poor overall survival (HR = 1.55, 95% CI = 1.27–1.88; P < 0.001). Subgroup analyses revealed that high systemic immune-inflammation index indicated a worse overall survival in hepatocellular carcinoma ( P < 0.001), urinary cancers ( P < 0.001), gastrointestinal tract cancers ( P = 0.02), small cell lung cancer ( P < 0.05) and acral melanoma ( P < 0.001). Hazard ratio for systemic immune-inflammation index greater than the cutoff for cancer-specific survival was 1.44 ( P < 0.05). Conclusions: Elevated systemic immune-inflammation index is associated with a worse overall survival in many solid tumors. The systemic-inflammation index can act as a powerful prognostic indicator of poor outcome in patients with solid tumors.
Source: Oncotarget
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2730495368
FWCI: 2.081
Cites: 34
Cited by: 355
Related to: 10